This Week in PLoS Medicine: WHO’s PMTCT; WTO compulsory licenses; & more

Four new articles were published in PLoS Medicine this week:

Using a simulation model, Andrea Ciaranello and colleagues find that the latest WHO PMTCT guidelines plus better access to PMTCT programs, better retention of women in care, and better adherence to drugs are needed to eliminate pediatric HIV in Zimbabwe.

Reed Beall and Randall Kuhn describe their analysis of the use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995.

Linda Flinterman and colleagues report on the long-term mortality rate for individuals who have experienced a first venous thrombosis or pulmonary embolism, describing an ongoing elevated risk of death compared to controls for up to eight years after the event.

Jason Nickerson and Amir Attaran examine the vast inequities in medical pain relief around the world and argue that the global control of licit narcotics be shifted from the International Narcotic Control Board to WHO.

Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.